Skip to content
10-K

Annual Report

AMBIT BIOSCIENCES CORP

0001193125-14-108100

← back to feed
Filed
Mar 20, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Feb 28, 2014 17.92M sh
Capex FY 2013 · Dec 31, 2013 $613K
Capex FY 2013 · Dec 31, 2012 −$46K
Capex FY 2013 · Dec 31, 2011 $553K
Operating Cash Flow FY 2013 · Dec 31, 2013 −$27.3M
Operating Cash Flow FY 2013 · Dec 31, 2012 −$28.77M
Operating Cash Flow FY 2013 · Dec 31, 2011 −$39.63M
Cash And Equivalents FY 2013 · Dec 31, 2013 $71.19M
Cash And Equivalents FY 2013 · Dec 31, 2012 $17.48M
Cash And Equivalents FY 2013 · Dec 31, 2011 $16.42M
Cash And Equivalents FY 2013 · Dec 31, 2010 $37.85M
Stockholders Equity FY 2013 · Dec 31, 2013 $57.59M
Stockholders Equity FY 2013 · Dec 31, 2012 −$198.25M
Stockholders Equity FY 2013 · Dec 31, 2011 −$177.36M
Stockholders Equity FY 2013 · Dec 31, 2010 −$143.43M
Current Liabilities FY 2013 · Dec 31, 2013 $16.36M
Current Liabilities FY 2013 · Dec 31, 2012 $29.83M
Current Assets FY 2013 · Dec 31, 2013 $73.1M
Current Assets FY 2013 · Dec 31, 2012 $18.71M
Total Assets FY 2013 · Dec 31, 2013 $73.95M
Total Assets FY 2013 · Dec 31, 2012 $19.99M
Sga Expense FY 2013 · Dec 31, 2013 $10.34M
Sga Expense FY 2013 · Dec 31, 2012 $6.55M
Sga Expense FY 2013 · Dec 31, 2011 $8.91M
Rd Expense FY 2013 · Dec 31, 2013 $26.28M
Rd Expense FY 2013 · Dec 31, 2012 $36.73M
Rd Expense FY 2013 · Dec 31, 2011 $50.71M
Net Income FY 2013 · Dec 31, 2013 −$11.2M
Net Income FY 2013 · Dec 31, 2012 −$26.65M
Net Income FY 2013 · Dec 31, 2011 −$37.63M
Operating Income FY 2013 · Dec 31, 2013 −$7.03M
Operating Income FY 2013 · Dec 31, 2012 −$23.15M
Operating Income FY 2013 · Dec 31, 2011 −$33.66M